Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
14 April, 2021 19:59 IST
Indoco Remedies Q3 consolidated net profit jumps 179% to Rs 253.6 mn
Source: IRIS | 10 Feb, 2021, 09.30AM
Rating: NAN / 5 stars.
Comments  |  Post Comment

  Indoco Remedies is India based Pharmaceuticals company, on February 9, reported a 178.68% rise in its consolidated net profit to Rs 253.6 million for the quarter-ended December.

The company had posted a net profit of Rs 91 million for the corresponding period of the previous fiscal.

Net sales of the company grew 17.71% to Rs 3,336.6 million for the quarter compared to Rs 2,834.5 million for the same period a year ago.

EBIDTA to net sales for the quarter is 18% at Rs 600 million, compared to 12.4% at Rs 351 million, same quarter last year.

Total expenses increased 5.74% to Rs 2,950.2 million for the quarter compared to Rs 2,790  million for the same period a year ago.

Indoco Remedies EPS has increased to Rs 2.75 in December 2020 from Rs 0.99 in December 2019.

Commenting on the third quarter FY21 results, Aditi Panandikar, Managing Director, Indoco Remedies said, "While the revenue from International business has registered a robust growth of 73%, we are yet to see revival in the Domestic business. Uptrend in EBIDTA has continued in the 3rd quarter at 18% of net sales, which is highly encouraging."

 Shares of the company gained Rs 1.65, or 0.52%, to settle at  Rs 314.55.  The total volume of shares traded  was  24,678 at the BSE (Tuesday).

 Post Comment
Name Email
Security Code type    into this box
Related Articles
Nagpur Power & Industries gets nod to increase stake in subsidiary company - 14-Apr-2021 20:29
Inox Leisure starts commercial operations of Multiplex Cinema Theatre in Bangalore - 14-Apr-2021 19:03
Venus Remedies enters into partnership with West Pharmaceutical Services - 14-Apr-2021 17:30
IDBI Capital maintains Accumulate on TCS with target of Rs 3,530 - 14-Apr-2021 12:31
TCS 4QFY21: Strong FY21 exit rate and deal wins to drive growth in FY22: Motilal Oswal - 14-Apr-2021 09:21
ELGi partners with Italian Red Cross to maintain critical COVID-19 response vehicles - 14-Apr-2021 08:50
Apollo Tyres launches cross-ply rib tyre for steer axles in CVs - 12-Apr-2021 18:40
Shri Bajrang Alliance donates 200 Oximeters to prevent Covid-19 situation in Raipur - 12-Apr-2021 18:25
Salora International board approves to sell property in UP - 12-Apr-2021 13:56
Ratnamani Metals & Tubes wins order worth Rs 5,940 mn - 12-Apr-2021 13:21
Kalpataru Power arm secures orders worth Rs 12.62 bn - 12-Apr-2021 13:07
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer